Fundamental Analysis of HYPERFINE INC(NASDAQ:HYPR) stock

Fundamental Rating

Overall HYPR gets a fundamental rating of 3 out of 10. We evaluated HYPR against 192 industry peers in the Health Care Equipment & Supplies industry. HYPR has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, HYPR is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

HYPR had negative earnings in the past year.

HYPR had a negative operating cash flow in the past year.

1.2 Ratios

With a Return On Assets value of -46.96%, HYPR is not doing good in the industry: 65.10% of the companies in the same industry are doing better.

Looking at the Return On Equity, with a value of -52.42%, HYPR is in line with its industry, outperforming 46.35% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-46.96%
ROE	-52.42%
ROIC	N/A

ROA(3y)-44.52%

ROA(5y)N/A

ROE(3y)-48.79%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HYPR has a Gross Margin of 43.12%. This is in the lower half of the industry: HYPR underperforms 60.94% of its industry peers.

HYPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	43.12%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HYPR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for HYPR has been increased compared to 1 year ago.

HYPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -0.83, we must say that HYPR is in the distress zone and has some risk of bankruptcy.

HYPR has a Altman-Z score (-0.83) which is comparable to the rest of the industry.

There is no outstanding debt for HYPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-0.83

ROIC/WACCN/A

WACC10.03%

2.3 Liquidity

A Current Ratio of 10.14 indicates that HYPR has no problem at all paying its short term obligations.

With an excellent Current ratio value of 10.14, HYPR belongs to the best of the industry, outperforming 91.15% of the companies in the same industry.

A Quick Ratio of 9.39 indicates that HYPR has no problem at all paying its short term obligations.

The Quick ratio of HYPR (9.39) is better than 92.19% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	10.14
Quick Ratio	9.39

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HYPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.27%, which is quite impressive.

Looking at the last year, HYPR shows a very strong growth in Revenue. The Revenue has grown by 61.90%.

The Revenue has been growing by 234.79% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)40.27%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q21.05%

Revenue 1Y (TTM)61.9%

Revenue growth 3Y234.79%

Revenue growth 5YN/A

Revenue growth Q2QN/A

3.2 Future

Based on estimates for the next years, HYPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.85% on average per year.

The Revenue is expected to grow by 17.79% on average over the next years. This is quite good.

EPS Next Y10.34%

EPS Next 2Y8.51%

EPS Next 3Y9.85%

EPS Next 5YN/A

Revenue Next Year6.2%

Revenue Next 2Y15.93%

Revenue Next 3Y17.79%

Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HYPR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year HYPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y8.51%

EPS Next 3Y9.85%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HYPR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HYPERFINE INC

NASDAQ:HYPR (5/2/2024, 7:00:01 PM)

Premarket: 0.7811 -0.01 (-1.49%)

0.7929

-0.01 (-1.02%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap57.05M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-46.96%
ROE	-52.42%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	43.12%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	10.14
Quick Ratio	9.39
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)40.27%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y10.34%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)61.9%

Revenue growth 3Y234.79%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

HYPERFINE INC (HYPR)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens